Jul. 27, 2017
Opening arguments in Johnson & Johnson talc trial present opposite views of what science shows
Attorneys for a dying woman urged a jury on Wednesday to find that the company should have warned consumers about baby powder
LOS ANGELES — Attorneys for a dying woman who is the plaintiff in the first Johnson & Johnson talcum powder case to go to trial in California urged a jury on Wednesday to find that the company should have warned consumers its baby powder increased the risk of ovarian cancer.
The bellwether case comes after the company has lost four out of five jury trials in Missouri, totaling over $300 million in verdicts.
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In